Small molecule-switchable RNA platform enables control of therapeutic protein expression

FHS
January 2, 2024
11:27 am

Just like a doctor adjusts the dose of a medication to the patient’s needs, the expression of therapeutic genes, those modified in a person to treat or cure a disease via gene therapy, also needs to be maintained within a therapeutic window.

Researchers identify a new approach to controlling bacterial infections

Researchers at the Icahn School of Medicine at Mount Sinai have identified a new approach to controlling bacterial infections.

February 7, 2024

Coherus and AbbVie settle Humira biosimilar dispute after Mark Cuban’s Cost Plus Drugs announcement

Biosimilars player Coherus Biosciences has patched things up with AbbVie after the pharma said Coherus violated its non-exclusive license to commercialize Yusimry, a biosimilar of

June 15, 2023

OCT Angioplasty Win; Congenital Defect Found in Bronny James; Gene Tx for Angina

Cardiovascular mortality in the U.S. fell substantially from 1968 to 2019, but the pace of decline slowed in the last decade, death certificates suggest. (European

August 30, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.